Hydrochloride anlotinib
CC-RT-ALTER-01
Unknown small_molecule active
Quick answer
Hydrochloride anlotinib for Uterine Cervical Neoplasms is a Unknown program (small_molecule) at Zhongnan Hospital with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Zhongnan Hospital
- Indication
- Uterine Cervical Neoplasms
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active